Increasing incidence of testicular cancer--birth cohort effects
- PMID: 9524583
- DOI: 10.1111/j.1699-0463.1998.tb01340.x
Increasing incidence of testicular cancer--birth cohort effects
Abstract
The incidence of testicular cancer is rising in most Western populations. A collaborative study between nine population-based cancer registries in countries around the Baltic Sea was utilized in order to analyze in detail geographic variations and temporal trends in the occurrence of testicular cancer. There were 34,309 cases registered up until 1989 starting in Denmark in 1942 and most recently in Latvia in 1977. From the descriptive epidemiology it was obvious that there was a substantial variation in the age-standardized incidence amounting to about a 10-fold difference between the different countries ranging from 0.8 per 100,000 person-years in Lithuania to 7.6 per 100,000 person-years in Denmark. Previous studies have indicated that this increase is due to birth cohort effects. A more detailed analysis was therefore performed in those six countries with a sufficiently long period of cancer registration; Poland, former East Germany, Norway, Finland, Denmark and Sweden. This analysis showed that birth cohort is a more important determinant of testicular cancer risk than year of diagnosis. In Poland, former East Germany and Finland, there was an increasing risk for all birth cohorts. Among men born in Denmark, Norway or Sweden between 1930 and 1945, this increasing trend in risk was interrupted in these birth cohorts but followed thereafter by an uninterrupted increase by birth cohort. In conclusion, life time exposure to environmental factors which are associated with the incidence of testicular cancer appear to be more related to birth cohort than to year of diagnosis. Because testicular cancer typically occurs at an early age, major etiological factors therefore need to operate early in life, perhaps even in utero.
Similar articles
-
Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon.J Natl Cancer Inst. 1996 Jun 5;88(11):727-33. doi: 10.1093/jnci/88.11.727. J Natl Cancer Inst. 1996. PMID: 8637026
-
Testicular cancer incidence in eight northern European countries: secular and recent trends.Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2157-66. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15598775
-
Trends in testicular cancer incidence in the Nordic countries, focusing on the recent decrease in Denmark.Int J Androl. 2006 Feb;29(1):199-204. doi: 10.1111/j.1365-2605.2005.00605.x. Epub 2005 Dec 20. Int J Androl. 2006. PMID: 16371112
-
Interpreting the international trends in testicular seminoma and nonseminoma incidence.Nat Clin Pract Urol. 2006 Oct;3(10):532-43. doi: 10.1038/ncpuro0606. Nat Clin Pract Urol. 2006. PMID: 17031378 Review.
-
Testicular cancer.Cancer Surv. 1994;19-20:323-41. Cancer Surv. 1994. PMID: 7534631 Review.
Cited by
-
International trends in the incidence of testicular cancer, 1973-2002.Cancer Epidemiol Biomarkers Prev. 2010 May;19(5):1151-9. doi: 10.1158/1055-9965.EPI-10-0031. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20447912 Free PMC article.
-
Future of testicular germ cell tumor incidence in the United States: Forecast through 2026.Cancer. 2017 Jun 15;123(12):2320-2328. doi: 10.1002/cncr.30597. Epub 2017 Feb 27. Cancer. 2017. PMID: 28241106 Free PMC article.
-
Spatial variation and temporal trends of testicular cancer in Great Britain.Br J Cancer. 2001 Jun 1;84(11):1482-7. doi: 10.1054/bjoc.2001.1739. Br J Cancer. 2001. PMID: 11384098 Free PMC article.
-
Adolescent and adult risk factors for testicular cancer.Nat Rev Urol. 2012 Apr 17;9(6):339-49. doi: 10.1038/nrurol.2012.61. Nat Rev Urol. 2012. PMID: 22508459 Free PMC article. Review.
-
Space-time analysis of testicular cancer clusters using residential histories: a case-control study in Denmark.PLoS One. 2015 Mar 10;10(3):e0120285. doi: 10.1371/journal.pone.0120285. eCollection 2015. PLoS One. 2015. PMID: 25756204 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical